Asthma is characterized by chronic inflammation of the airway wall with the presence of activated Th 2 lymphocytes. The current study assessed the ability of Th 2 cytokines to modulate fibroblast-mediated contraction of collagen gels in order to determine if Th 2 cytokines could contribute to tissue remodeling by altering mesenchymal cell contraction. Human fetal lung fibroblasts, human adult bronchial fibroblasts and human airway smooth muscle cells were cast into native type I collagen gels and allowed to contract in the presence or absence of IL-4, IL-5, IL-10 or IL-13. IL-4 and IL-13 but not IL-5 and IL-10 augmented collagen gel contraction in a concentration-dependent manner. Neither IL-4 nor IL-13 altered fibroblast production of TGF-ß or fibronectin. Both, however, decreased fibroblast PGE 2 release.
INTRODUCTION
Asthma is a chronic inflammatory disease characterized by reversible airflow limitation and the presence of chronic inflammation of the airways (4, 10) . In addition, the airways in asthma undergo characteristic structural alterations. This remodeling may contribute not only to the development of increased airway reactivity, but may also lead to fixed airflow limitation.
A characteristic feature of inflammation in asthma is the accumulation of activated T helper 2 (Th 2 ) lymphocytes (11, 24) . These lymphocytes release a characteristic set of cytokines which are believed to play a major role in the airways reactivity which characterizes asthma. Fibroblasts are also able to respond to selected Th 2 cytokines suggesting the possibility that mesenchymal cell participation in airways remodeling may also be, at least in part, controlled by these cytokines (5, 18, 25) .
Among the features which characterize wound healing and the development of fibrotic scar is tissue contraction. This process is thought to be mediated by fibroblast contraction of extracellular matrices. Such a process developing circumferentially around an airway could contribute to progressive, fixed airflow limitation. The current study, therefore, was designed to evaluate the hypothesis that Th 2 cytokines might contribute to airway remodeling by modulating fibroblast contraction of extracellular matrices. To evaluate this hypothesis, the well-established in vitro system utilizing fibroblasts cultured in floating three-dimensional collagen gels was utilized.
Materials and Methods

Materials
Native type I collagen (Rat Tail Tendon Collagen, RTTC) was extracted from rat tail tendons by a previously published method (1, 15) . Briefly, tendons were excised from rat tails, and the tendon sheath and other connective tissues were removed carefully. Repeated washing with Tris -buffered saline was followed by dehydration and sterilization with 50%, 75%, 95% and pure ethanol. Type I collagen was then extracted in 6mM hydrochloric acid at 4°C. 20724.1), TGF-ß1, TGF-ß2, TGF-ß3, and biotinylated anti-TGF-ß1, ß2, or ß3 antibodies were from R&D system (Minneapolis, MN). Hydroxyproline, collagenase, chloramine T, n-propanol, p-dimethylaminobenzaldehyde, prostaglandin E 2 , tetramethyl-Benzidine (TMB) were purchased from Sigma (St. Louis, MO). The Prostaglandin E 2 EIA kit, and COX-1 and COX-2 electrophoresis standards, were purchased from Cayman Chemical (Ann Arbor, MI). Anti-COX-1 polyclonal antibody, anti-COX-2 polyclonal antibody, and HRP-conjugated anti-goat-IgG were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Western blot detection reagents (ECL) were purchased from Amersham Pharmacia Biotech (Alameda. CA). HRPstreptavidin was from Zymed (San Francisco, CA).
Cell Culture
Human fetal lung fibroblasts (HFL-1, Lung, diploid, human) and human bronchial fibroblasts (HBF) were purchased from the American Type Culture Collection (Rockville, MD). Human airway smooth muscle cells (HASMC) prepared as described (Kotlikoff, Panetteri) were obtained from Dr. Myron Toews (UNMC, Omaha, NE). The cells were cultured in Dulbecco's modified Eagle medium (DMEM; GIBCO), supplemented with 10% fetal calf serum (FCS), 100 µg/ml penicillin, 250 µg/ml streptomycin, 1.25 µg/ml fungizone and 2 mM L-glutamine. Cells were refed three times weekly in 100 mm tissue culture dishes (Becton Dickinson Labware, Lincoln Park, NJ), and confluent cells were passaged at a 1:4 ratio.
Collagen gel preparation and contraction assay
Gels were prepared using a previously described method (16) by mixing RTTC, distilled water and 4-times concentrated DMEM so that the final mixture resulted in a physiologic ionic strength, 1 x DMEM and a pH of 7.40. Cells were trypsinized (Trypsin-EDTA; 0.05% trypsin, 0.53 mM EDTA-4Na, GIBCO) and suspended in serumfree DMEM (SF-DMEM) at a density of 10 7 cells/ml. Cells were then mixed with the neutralized collagen solution so that the final cell density in the collagen solution was 4x10 5 cells/ml, and the final concentration of collagen was 0.75 mg/ml. Aliquots (0.5ml/well) of the mixture of cells in collagen were cast into each well of 24-well tissue culture plates (FALCON). After gelation was completed, normally within 20 minutes at room temperature, the gels were gently released from the 24-well tissue culture plates and transferred into 60 mm tissue culture dishes (3 gels in each dish), which contained 5 ml of freshly prepared SF-DMEM with or without cytokines. The gels were then incubated at 37°C in a 5% CO 2 atmosphere for 3-5 days and the area of each gel was measured with an Optomax V image analyzer (Optomax, Burlington, MA)
daily. Data were expressed as the percentage of area compared to the original gel size.
Hydroxyproline measurement
Hydroxyproline amount was quantified with a modification of a previously published method (22) . Briefly, gels were centrifuged at 6000g for 5 minutes to eliminate the water and then dissolved with collagenase (0.25mg/ml, 50 µl/gel).
Supernatant was separated from cell pellets by centrifuging at 2000g for 5 minutes. 
DNA assay
To estimate cell number in 3-dimensional collagen gels, DNA was assayed fluorometrically with Hoechst dye 33258 (Sigma) by a modification of a previously published method (12) . Collagen gels were dissolved with collagenase (0.25mg/ml in SF-DMEM, 0.5 ml/gel) for 2 hours at 37°C. Cell pellets and supernatants were separated by centrifugation at 500 x g for 10 minutes and frozen at -80°C overnight.
Cells were then thawed and re-suspended in 1 ml of distilled water. Following this, the samples were briefly sonicated and the suspensions were mixed thoroughly with 2ml of TNE buffer (3M NaCl, 10 mM Tris, 1.5mM EDTA, pH 7.4) containing 2 µg/ml of 
Measurement of TGF-ß isoforms and fibronectin by ELISA
TGF-ß and fibronectin in the media in which gels were floated and the supernatant solutions after gel digestion (see DNA assay) was determined by ELISA.
Quantification of fibronectin was performed by an ELISA that is specific for human fibronectin and which does not detect bovine fibronectin (23) . Quantification of TGF-ß isoforms was performed as follows. Plates were coated with monoclonal anti-TGF-ß1, ß2 or ß3 antibodies, respectively, at 4°C overnight. After washing 3 times (5 minutes each), standards and samples were added and incubated at room temperature for 2 hours. All samples were assayed both untreated and following TGF-ß activation by acidification and neutralization. To accomplish this, a 500 µl sample was mixed with 100 µl of 1N HCL and, after 10 minutes at room temperature, neutralized with 100 µl of 1.2N NaOH/0.5M HEPES. After washing, bound antigen was detected after adding biotinylated-anti-TGF-ß1, ß2 or ß3 antibodies for 1 hour at room temperature. Horse radish peroxidase-streptoavidin (1:20,000 dilution) was then added for 1 hour. Bound HRP was then detected with 3, 3',5, 5' -tetramethylbenzidine (TMB). The reaction was stopped with 1M H 2 SO 4 and the product quantified at 450 nm with a microplate reader.
Measurement of PGE 2 by EIA
Prostaglandin E 2 concentration in the media in which gels were floated, as well as in the solubilized gels, was quantified using a enzyme immunoassay following the manufacturer's instructions (Cayman Chemical Co., Ann Arbor, MI.).
Western blotting
HFL-1 cells were mixed with neutralized type I collagen solutions and then cast into 6-well tissue culture plates at a density of 4 x10 5 /ml (2ml/well). After gelation, gels were fed with-serum free DMEM with or without 25ng/ml (2ml/well) of IL-4, IL-5, IL-10 or IL-13. The gels were then released and allowed to contract in the medium for 48
hours. Cell pellets were obtained by digesting the gels with collagenase (0.25 mg/ml in SF-DMEM) for 2 hours at 37°C followed by centrifugation at 500 x g for 10 minutes.
Cell pellets were then treated with lysis buffer (35mM Tris-HCl, pH 7.4, 0.4 mM EGTA, 10 mM MgCl 2 , 100 µg/ml aprotinin, 1 µM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, and 0.1% Triton X-100). Lysates were briefly sonicated on ice and centrifuged at 10,000 x g for 3 minutes. The protein concentration in the supernatants was measured (BIO-RAD Protein Assay reagents, Cat #165-5035:, Hercules, CA).
Ten percent polyacrylamide gels were prepared and SDS-polyacrylamide gel electrophoresis was performed under reducing conditions. Cell lysate proteins were diluted with 2 x concentrated sample buffer (250mM Tris-HCl ph 6.8, 4% SDS, 10% glycerol, 0.006% bromophenol blue, 2% ß-mercaptoethanol) and heated at 95°C for 5 minutes before loading (5µg/lane). The resolved proteins were transferred onto
Immuno-Blot PVDF (BIO-RAD) following the manufacture's instructions. The PVDF membrane was blocked and then incubated with 1µg/ml of anti-COX-1 or anti-COX-2 polyclonal antibody (Santa Cruz Biotech, Santa Cruz, CA). HRP-conjugated anti-goatIgG was then allowed to bind and, after washing, the blots were probed with the ECL Western blot detection system according to the manufacture's instructions (Amersham Pharmacia Biotech, Alameda, CA).
RNA Isolation and Complementary DNA Synthesis
After 48 hours of contraction, collagen gels were digested with collagenase (0.25mg/ml in RNAse-free PBS) at 37°C and 5% CO 2 for 2 hours. Total RNA was then extracted from the cell pellets with acid guanidine monothiocyanate, precipitated with isopropyl alcohol, and dissolved in TE buffer. The total RNA amount was quantified spectrophotometrically. To remove possible contaminating genomic DNA, 1 µg of total RNA was treated with DNAse I following the manufacture's instruction (GIBCO, Rockville, MD) for 15 minutes at room temperature, after which the reaction was stopped with 25 mM EDTA and the sample heated to 65°C for 10 minutes followed by 
Statistical Analysis
Each condition in the experiments of collagen gel contraction included three replicate gels, and the data from individual experiments are presented as the means ± SEM of triplicates. Replica experiments, each with triplicate replicates, were performed on separate occasions. Student's t test was performed to compare two group data. For multiple comparisons, ANOVA was performed followed by Tukey test to make pair-wise comparisons. p<0.05 was considered significant.
RESULTS
Effects of Th 2 cytokines on collagen gel contraction mediated by human lung mesenchymal cells
To investigate Th 2 cytokine modulation of collagen gel contraction, the effect of IL-4, IL-5, IL-10 and IL-13 on collagen gel contraction mediated by HFL-1 cells was first tested by adding 10ng/ml of each cytokine into the medium in which gels were floated. Both IL-4 and IL-13 significantly augmented the collagen gel contraction mediated by HFL-1 cells (Figure 1 ), while IL-5 and IL-10 had no effect on the contraction. The augmenting effect of IL-4 and IL-13 was observed within 24 hours after release, and it was due neither to degradation of the collagen (Figure 2A ) nor to increasing cell numbers in the gels ( Figure 2B ). Furthermore, both IL-4 and IL-13
augmented the collagen gel contraction in a concentration-dependent manner over a range of 10 -9 to 10 -6 M ( about 0.1-10ng/ml) although IL-4 was slightly more potent than IL-13 ( Figure 3 ). Similar effects of IL-4, IL-5, IL-10 and IL-13 were also seen for the gel contraction caused by adult human bronchial fibroblasts (HBF) and adult human airway smooth muscle cells (HASMC), although IL-13 effect is less potent than IL-4 in HBF ( Table 1 ).
The cytokine effect on TGF-ß and fibronectin production by HFL-1 cells in 3-dimensional collagen gels
It is known that TGF-ß and fibronectin are able to enhance collagen gel contraction by human lung fibroblasts. To determine whether TGF-ß and fibronectin mediate the augmenting effect of IL-4 and IL-13 on collagen gel contraction, TGF-ß1,2,3 and fibronectin production in the contracting gel cultures was evaluated in response to IL-4 and IL-13 . As shown in table 2, fibronectin production by HFL-1 cells was not statistically different in response to IL-4 or IL-13. Similarly, there was no effect of the cytokines on TGF-ß1 production. TGF-ß2 and TGF-ß3 were not detectable in any condition.
Cytokine effect on prostaglandin E 2 (PGE 2 ) production by HFL-1 cells in 3-dimensional collagen gels
Since PGE 2 is an inhibitor of collagen gel contraction by fibroblasts, we examined the effect of Th 2 cytokines on PGE 2 production in the 3-dimensional culture system. The concentration of PGE 2 was 30-to 40-fold higher in the collagen gels than in the surrounding culture medium. IL-4 significantly reduced the concentration in both the medium (Figure 4a ) and in the gels (Figure 4b ) while IL-13 reduced PGE 2 concentration in the gels (Figure 4b ). IL-5 significantly increased the PGE 2 production and IL-10 had no effect ( Figure 4A IL-4 inhibition of PGE 2 production by human lung fibroblasts may contribute to asthma by modulating both airway reactivity and remodeling.
A number of other mediators have been described which can modulate mesenchymal cell mediated matrix contraction. Among these are TGF-ß and PDGF, two mediators which are thought to play prominent roles in tissue repair (9, 17) . Both of these mediators are potent augmenters of tissue contraction. The current study suggests that IL-4 and IL-13 can exert effects, at least with regard to collagen gel contraction which are similar to TGF-ß and PDGF.
Previous studies have demonstrated that fibroblasts cultured in Type I collagen gels produce PGE 2 which can function as an endogenous inhibitor of collagen gel contraction (27) . In the current study, IL-4 and IL-13 appeared to augment collagen gel contraction in large part by the inhibition of PGE 2 which functions as a paracrine inhibitor. The mechanism by which IL-4 and IL-13 inhibit PGE 2 appears to be due to inhibition of expression of the cyclooxygenase enzymes, which are the key regulatory steps in conversion of arachidonic acid to prostaglandins. In this context, IL-4 and IL-13 differ significantly from TGF-ß.
In contrast to the inhibitory effect on cyclooxygenase expression and PGE 2 production induced by IL-4 and IL-13, TGF-ß stimulates PGE 2 production by increasing cyclooxygenase expression (31). This suggests that TGF-ß stimulates contraction while, at the same time, stimulating an endogenous down-regulator of the contractile process. This raises the interesting possibility that a repair response mediated by TGF-ß might be significantly altered in the concurrent presence of IL-4 or IL-13 which might disrupt endogenous paracrine counter regulatory pathways.
Limited studies have been performed with the concurrent presence of IL-4 and TGF-ß.
Interestingly, collagen gel contraction is greater in the presence of both mediators than that observed with either mediator alone. The mechanisms of the interaction are currently under investigation.
In the current study, IL-4 and IL-13 were able to augment collagen gel contraction even in the presence of indomethacin, which completely blocked prostaglandin E production. This suggests that while much of the effect of IL-4 and IL-13 is likely due to modulating PGE 2 auto-regulation, additional effects leading to augmented contraction are also, in part, responsible for the augmented contraction.
The mechanism for these additional effects remains to be defined.
In summary, the current study demonstrates that IL-4 and IL - Native type I collagen gels were prepared and released into 60mm tissue culture plate containing 5ml SF-DMEM with or without cytokines. After 48 hours of contraction, the media surrounding the gels were harvested and gels were dissolved with collagenase (0.25mg/ml, 500µl/gel). Total PGE 2 was then quantified in the medium and solubilized gels by EIA. Panel A: PGE 2 concentration in the surrounding medium. Native type I collagen gels were prepared and released into 60 mm dishes containing SF-DMEM with or without 2µM indomethacin in the presence or absence of IL-4 or IL-13 (10ng/ml). Media in which gels were floated were harvested after 3 days , and PGE 2 amounts were measured by EIA as described in the Materials and Methods. culture conditions. *p<0.05 by t test, comparing to control. 
